HOUSTON – It’s a revolution in cancer treatment, and it’s available right here in Houston.
Meet the local oncologist who is giving patients new hope in the fight against the disease.
Dr. Philip Salem, oncologist and founder of Salem Oncology, recently stopped by Houston Life, alongside his patient, Hans Lengers, to chat about ICTriplex and its groundbreaking clinical results.
ICTriplex is the first approach to combine all three major systemic therapies - immunotherapy, chemotherapy, and targeted therapy - simultaneously.
“Immunotherapy has changed the landscape of the treatment. The problem is how to use immunotherapy, how to use chemo, how to use targeted therapy – there’s a lot of art and science in that,” said Dr. Salem.
What makes it even more unique is that each patient’s treatment is personalized, tailored to their biological and genomic tumor profile. This has never been done at this scale before.
He also explains, “The innovation is how we use them, and how we combine them, and I feel at this point in time patients who exhaust all standard and conventional therapy, the best option they have is ICTriplex.”
Watch the full interview to learn more.
Visit www.SalemOncology.com or call 713-796-1221 to connect with Dr. Salem and Salem Oncology Center.